Kolexia
Doucet Ludovic Oncologie médicale
Doucet Ludovic
Oncologie médicale
Institut de cancérologie de l'Ouest
Saint-Herblain, France
85 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Métastase tumorale Carcinome pulmonaire à petites cellules Carcinomes Néphrocarcinome Thromboembolie Thromboembolisme veineux Glioblastome

Collaborateurs

Voir plus
Culine Stephane
Culine Stephane
Hôpital Saint-Louis, Paris, France
Gauthier Helene
Gauthier Helene
Hôpital Saint-Louis, Paris, France
Defaucheux Cecile
Defaucheux Cecile
Centre Hospitalier d'Arcachon, La Teste-de-Buch, France
Torossian Nouritza
Torossian Nouritza
Centre Hospitalier Régional D'Orléans Hôpital de La Source, Orléans, France

Industries

Voir plus
Amgen
5 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2022
Genactis SAS
5 collaboration(s)
Dernière en 2022
A+A
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer.
Clinical lung cancer   13 décembre 2023
PersoMed-I: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma (PersoMed-I)
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 décembre 2023
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
Association between post-operative hPG (circulating progastrin) detectable level and worse prognosis in glioblastoma.
ESMO open   13 septembre 2023
UCPVax: Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer : A Phase I/II Study
Essai Clinique (Invectys)   13 juillet 2023
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 septembre 2022
GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized, double-blind trial.
2022 ASCO Annual Meeting I   02 juin 2022
Prognostic value of hPG80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.
2022 ASCO Annual Meeting I   02 juin 2022
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study.
Rheumatology (Oxford, England)   29 décembre 2021
Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   22 décembre 2021